Recherche
-
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial
(Journal of Infection. vol. 88, n° 3, pp. 106120, 2024-02-16)Article de revueLibre accès -
Plasma Markers of Neutrophil Extracellular Trap Are Linked to Survival but Not to Pulmonary Embolism in COVID-19-Related ARDS Patients
(Frontiers in Immunology. vol. 13, 2022-03-17)Article de revueLibre accès -
Evolution of patients' socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients
(PLoS ONE. vol. 13, n° 7, pp. e0199874, 2018-07-05)Article de revueLibre accès -
Depression and anxiety symptoms in young adults before and during the COVID-19 pandemic: evidence from a Canadian population-based cohort
(Annals of General Psychiatry. vol. 20, n° 1, pp. 42, 2021-09-08)Article de revueLibre accès -
Trabectedin plus durvalumab in patients with advanced pretreated soft tissue sarcoma and ovarian carcinoma (TRAMUNE): an open-label, multicenter phase Ib study
(Clinical Cancer Research, 2021-12-29)Article de revue -
Transethnic, Genome-Wide Analysis Reveals Immune-Related Risk Alleles and Phenotypic Correlates in Pediatric Steroid-Sensitive Nephrotic Syndrome
(Journal of the American Society of Nephrology. vol. 29, n° 7, pp. 2000-2013, 2018-07)Article de revue -
Direct, indirect and total effect of HIV coinfection on the risk of non-liver-related cancer in hepatitis C virus-infected patients treated by direct-acting antivirals: a mediation analysis
(HIV Medicine, 2021-08-17)Article de revueLibre accès -
Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort
(PLoS ONE. vol. 13, n° 12, pp. e0208657, 2018-12-18)Article de revueLibre accès -
Implementing an outpatient clinical trial on COVID-19 treatment in an emergency epidemic context: a mixed methods study among operational and research stakeholders within the Coverage trial, Bordeaux (France)
(Archives of Public Health. vol. 80, n° 1, 2022-12-03)Article de revueLibre accès -
Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH)
(Nutrients. vol. 12, n° 9, 2020-08-21)Article de revueLibre accès